Lobbyist information

Amount

Anthony Magnetti

$19,185.25

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2014 All issues related to payment reform, pharmaceuticals, recycling and disposal policies, provider and industry practices related to pharmaceuticals, prescribing, dispensing, and monitoring controlled substances and related policies, mental health patient access and prescribing related policies, research and development, taxation policies, drug safety Possible legislation to be lobbied includes: FY2015Budget Chapter 224 the Acts of 2012, (section 275) An Act Improving The Quality Of Health Care and Reducing Costs Through Increased Transparency, Efficiency and Innovation; Chapter 139 the Acts of 2012 (section 186) AN ACT MAKING APPROPRIATIONS FOR THE FISCAL YEAR 2013 FOR THE MAINTENANCE OF THE DEPARTMENTS, BOARDS, COMMISSIONS, INSTITUTIONS AND CERTAIN ACTIVITIES OF THE COMMONWEALTH, FOR INTEREST, SINKING FUND AND SERIAL BOND REQUIREMENTS AND FOR CERTAIN PERMANENT IMPROVEMENTS H27 An Act Making Uniform the Law Regarding Trade Secrets H825 An Act Regulating the Disposal of Prescription Medication H978 An Act Relative to Pre-Authorization of Medical and Health Care Services H1676 An Act Criminalizing the Possession of Ingredients for Manufactured Drugs H1927 An Act Relative to the Substitution of Interchangeable Biosimilars H1962 An Act Relative to the Substitution of Generic Drugs H1977 An Act Relative to Drug Disposal by Mail Prescriptions H1978 An Act Relative to Responsible Prescription Prescribing H1993 An Act Relative to the Definition of Pharmacy H2082 An Act Establishing a Statewide Discount Program for Pharmaceuticals ,H3734,H3667 S484 An Act Regulating Pharmacists as Health Care Providers S1029 An Act Relative to Prescription Drug Adverse Event Reporting S1090 An Act to Ensure Safe Medication Administration S1220 An Act Relative to Medicare Part B S1334 An Act Updating the Research and Development Tax Credit S1360 An Act Relative to Tax Credits for Prescription Drugs H1052 An Act Relative to Prescription Drugs H1715 An Act Relative to Non-Competition Agreements H1729 An Act Relative to the Prohibition of Non-Competition Agreements H1933 An Act Establishing Provisions for the Return of Expired Pharmaceuticals H1988 An Act Relative to Suspending Prescription Drug Coverage from Minimum Creditable Coverage H2018 An Act to Define Modest Meals and Refreshments in Prescriber Educational Settings H2020 An Act to Reduce Healthcare Costs by Promoting Non-biased Prescriber Education S1050 An Act to Reduce Healthcare Costs by Promoting Non-biased Prescriber Education H2033 An Act Relative to Safe Disposal of Prescription Drugs H2061 An Act Prohibiting Advertising by Pharmaceutical Companies H2096 An Act Establishing a Special Commission to Study and Recommend Improvements in the Delivery of Prescription Drug Benefits for the Citizens of the Commonwealth H2646 An Act to Eliminate the Tax Deduction for Direct to Consumer Pharmaceutical Marketing S483 An Act Regulating Pharmacy Audits S543 An Act to Ensure the Privacy of Patient Prescription Records S569 An Act Relative to Mandatory Prescription Drug Coverage S846 An Act Relative to Employee Non-Competition Agreements S1051 An Act to Prevent Undue Influence on Prescriber Behavior S1052 An Act to Restore Integrity in the Marketing of Pharmaceutical Products and Medical Devices S1378 An Act Establishing a Health Care Electronic Prescribing Tax Credit H948 An Act to Expand Coverage & Access to Behavioral Health Services H1797 An Act Providing Equitable Access to Behavioral Health Services for MassHealth Consumers S519 An Act Providing Equitable Access to Behavioral Health Services for MassHealth Consumers S439 An Act Relative to Patient Medication Adherence S477 An Act Relative to Patient Protection S986 An Act to Protect Patients from Breakthrough Seizures

Katrina Iserman

$2,245.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2014 All issues related to payment reform, pharmaceuticals, recycling and disposal policies, provider and industry practices related to pharmaceuticals, prescribing, dispensing, and monitoring controlled substances and related policies, mental health patient access and prescribing related policies, research and development, taxation policies, drug safety Possible legislation to be lobbied includes: FY2015Budget Chapter 224 the Acts of 2012, (section 275) An Act Improving The Quality Of Health Care and Reducing Costs Through Increased Transparency, Efficiency and Innovation; Chapter 139 the Acts of 2012 (section 186) AN ACT MAKING APPROPRIATIONS FOR THE FISCAL YEAR 2013 FOR THE MAINTENANCE OF THE DEPARTMENTS, BOARDS, COMMISSIONS, INSTITUTIONS AND CERTAIN ACTIVITIES OF THE COMMONWEALTH, FOR INTEREST, SINKING FUND AND SERIAL BOND REQUIREMENTS AND FOR CERTAIN PERMANENT IMPROVEMENTS H27 An Act Making Uniform the Law Regarding Trade Secrets H825 An Act Regulating the Disposal of Prescription Medication H978 An Act Relative to Pre-Authorization of Medical and Health Care Services H1676 An Act Criminalizing the Possession of Ingredients for Manufactured Drugs H1927 An Act Relative to the Substitution of Interchangeable Biosimilars H1962 An Act Relative to the Substitution of Generic Drugs H1977 An Act Relative to Drug Disposal by Mail Prescriptions H1978 An Act Relative to Responsible Prescription Prescribing H1993 An Act Relative to the Definition of Pharmacy H2082 An Act Establishing a Statewide Discount Program for Pharmaceuticals ,H3734,H3667 S484 An Act Regulating Pharmacists as Health Care Providers S1029 An Act Relative to Prescription Drug Adverse Event Reporting S1090 An Act to Ensure Safe Medication Administration S1220 An Act Relative to Medicare Part B S1334 An Act Updating the Research and Development Tax Credit S1360 An Act Relative to Tax Credits for Prescription Drugs H1052 An Act Relative to Prescription Drugs H1715 An Act Relative to Non-Competition Agreements H1729 An Act Relative to the Prohibition of Non-Competition Agreements H1933 An Act Establishing Provisions for the Return of Expired Pharmaceuticals H1988 An Act Relative to Suspending Prescription Drug Coverage from Minimum Creditable Coverage H2018 An Act to Define Modest Meals and Refreshments in Prescriber Educational Settings H2020 An Act to Reduce Healthcare Costs by Promoting Non-biased Prescriber Education S1050 An Act to Reduce Healthcare Costs by Promoting Non-biased Prescriber Education H2033 An Act Relative to Safe Disposal of Prescription Drugs H2061 An Act Prohibiting Advertising by Pharmaceutical Companies H2096 An Act Establishing a Special Commission to Study and Recommend Improvements in the Delivery of Prescription Drug Benefits for the Citizens of the Commonwealth H2646 An Act to Eliminate the Tax Deduction for Direct to Consumer Pharmaceutical Marketing S483 An Act Regulating Pharmacy Audits S543 An Act to Ensure the Privacy of Patient Prescription Records S569 An Act Relative to Mandatory Prescription Drug Coverage S846 An Act Relative to Employee Non-Competition Agreements S1051 An Act to Prevent Undue Influence on Prescriber Behavior S1052 An Act to Restore Integrity in the Marketing of Pharmaceutical Products and Medical Devices S1378 An Act Establishing a Health Care Electronic Prescribing Tax Credit H948 An Act to Expand Coverage & Access to Behavioral Health Services H1797 An Act Providing Equitable Access to Behavioral Health Services for MassHealth Consumers S519 An Act Providing Equitable Access to Behavioral Health Services for MassHealth Consumers S439 An Act Relative to Patient Medication Adherence S477 An Act Relative to Patient Protection S986 An Act to Protect Patients from Breakthrough Seizures

Keith Stephen Osburn

$82.21

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2014 All issues and regulations related to payment reform, pharmaceuticals, recycling and disposal policies, provider and industry practices related to pharmaceuticals, prescribing, dispensing, and monitoring controlled substances and related policies, mental health patient access and prescribing related policies, research and development, taxation policies, drug safety

Total salaries paid:      $21,512.46

Lobbyist Entity information

Amount

McDermott, Quilty & Miller, LLP	$60,000.00
Employed Terminated 01/01/2014

Total salaries paid:      $60,000.00

Expenditures

Amount